Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Zithromax Settlement Signals More State Drug Advertising Oversight

Executive Summary

Pfizer's $6 mil. Zithromax settlement with 19 state attorneys general over promotions for the antibiotic signals an increase in state oversight of drug promotional practices

You may also be interested in...



Antibiotic Resistance, Drug Prescribing Trends To Be Tracked By Database

An FDA-contracted database will track emerging antibiotic resistance patterns and physician prescribing patterns

Antimicrobial Advertising Guidance Should Target Resistance - FDA Group

An FDA guidance on direct-to-consumer advertising of antimicrobials should address resistance issues, an agency-wide task force report suggests.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel